Lecture Notes: Cell Wall Synthesis in Bacteria and Antibiotics
Introduction to Cell Wall Synthesis as an Antibiotic Target
Cell wall synthesis in bacteria is a target for antibiotics due to low host toxicity.
Humans do not have peptidoglycan, making it an ideal target.
Beta-Lactam Antibiotics
Most cell wall targeting antibiotics contain a beta-lactam ring.
Common beta-lactam drugs include penicillins and cephalosporins.
Historical Background
Penicillin G
First beta-lactam antibiotic.
Discovered by Alexander Fleming in 1929 from Penicillium chrysogenum fungus.
Initially difficult to isolate; Fleming struggled to gain recognition for its importance.
Progress made in 1940 by Howard Florey and colleagues, highlighting its functionality.
Functionality of Penicillin
Penicillin G
Primarily effective against gram-positive bacteria (e.g., streptococci, pneumococcal infections).
Ineffective against gram-negative bacteria due to impermeability issues.
Semi-Synthetic Penicillins
Developed from penicillin G by altering side groups.
Some semi-synthetic variants can cross the outer membrane, making them effective against gram-negative bacteria.
Mechanism of Action
Beta-lactams are analogs of terminal amino residues in pentapeptide glycan subunits.
Structural similarity facilitates binding to transpeptidases (penicillin-binding proteins or PBPs).
Prevents the cross-linking step during cell wall synthesis.
Results in a compromised cell wall due to lack of cross-linking.
Impact on Bacterial Cells
Binding to penicillin-binding proteins inhibits catalysis of cell wall reactions.
Stimulates release of autolysins, enhancing degradation of existing cell wall.
Leads to a weakened cell wall and eventual cell lysis due to osmotic pressure.
Conclusion
Beta-lactam antibiotics play a crucial role in disrupting bacterial cell wall synthesis, leading to bacterial cell death, particularly in gram-positive bacteria.